Introduction Psoriasis is an inflammatory disease nowadays considered not only as a
cutaneous but as a systemic disease. Among the numerous comorbidities, psoriatic arthritis …

Psoriasis is a chronic systemic inflammatory disease. Due to systemic inflammation, it is
associated with many comorbidities. Among them, cardiovascular diseases represent the …

Observational, cross-sectional prevalence studies are costly and time-consuming. The
development of indirect methods estimating prevalence used to obtain faster, less …

Psoriasis is a chronic autoimmune pathological condition characterized by hyperactivation
of proinflammatory cytokines (IL-6, TNF-α, IL-17, IL-23, etc.). Severe drug-associated …

Psoriasis is a chronic skin condition that can significantly impact the quality of life of those
affected. As an autoimmune disease, it can lead to itchy, painful, and scaly patches on the …

In the past decade, our understanding of psoriasis pathogenesis has made significant steps
forward, leading to the development of multiple game-changing therapies. While psoriasis …

Objective Whether metformin and its adenosine 5 'monophosphate-activated protein kinase
(AMPK) activation protect from psoriasis risk is unconcluded. We investigated the effect of …

The effectiveness and safety of biological agents for treating psoriasis have been confirmed;
however, their effects on glucose metabolism biomarkers in psoriasis patients remain …

Psoriasis is a chronic systemic inflammatory disease accompanied by an activation of skin
dendritic cells with accumulation in the inflammatory foci of interleukin-23 and activated Th-1 …

Psoriasis is a chronic inflammatory disease characterized by aberrant keratinocyte
differentiation and hyperproliferation. In psoriasis, there is an abnormal cross-talk between …